Published in
The Lancet HIV, 7(8), p. e397-e407, 2021
DOI: 10.1016/s2352-3018(21)00071-0
Links
Tools
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
Journal article published in 2021 by
Onyema Ogbuagu,
Peter J. Ruane,
Daniel Podzamczer,
Laura C. Salazar,
Keith Henry,
David M. Asmuth,
David Wohl,
Richard Gilson 
,
Yongwu Shao,
Ramin Ebrahimi,
Stephanie Cox,
Alexander Kintu,
Christoph Carter,
Moupali Das,
Jared M. Baeten
and other authors.
,
Yongwu Shao,
Ramin Ebrahimi,
Stephanie Cox,
Alexander Kintu,
Christoph Carter,
Moupali Das,
Jared M. Baeten
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 